| Beta2AR positive |  | |
---|---|---|---|
 | HK2 positive | HK2 negative | P value |
Age | Â | Â | Â |
  ≤ 50 year | 23 | 12 | 0.102 |
  > 50 year | 43 | 44 |  |
Gender | Â | Â | 0.357 |
 Male | 51 | 47 |  |
 Female | 15 | 9 |  |
Hepatitis virus infection | Â | Â | 0.596 |
 HBV | 57 | 49 |  |
 HCV | 3 | 1 |  |
 HBV + HCV | 0 | 1 |  |
 None | 6 | 5 |  |
AFP level | Â | Â | 0.050 |
  ≤ 20ug/L | 26 | 32 |  |
  > 20ug/L | 40 | 24 |  |
Tumor number | Â | Â | 0.235 |
 Solitary | 65 | 53 |  |
 Multiple | 1 | 3 |  |
Tumor size | Â | Â | 0.091 |
  ≤ 5 cm | 40 | 42 |  |
  > 5 cm | 26 | 14 |  |
TNM stage | Â | Â | 0.006 |
 I | 26 | 18 |  |
 II | 18 | 31 |  |
 III | 16 | 6 |  |
 IV | 6 | 1 |  |
Differentiation | Â | Â | 0.229 |
 Well | 19 | 17 |  |
 Moderate | 28 | 30 |  |
 Poor | 19 | 9 |  |
Post operation treatment | Â | Â | 0.377 |
 None | 44 | 33 |  |
 TACE | 22 | 23 |  |